NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Inogen, Inc. (INGN) Stock Analysis

Inogen, Inc. (INGN) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

INGN

$6.67

−$0.02 (−0.30%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare INGN with… →

INGN Key Statistics

As of Oct 21, 2026
Trading
Open
$6.65
Previous Close
$6.69
Day's Range
6.59–6.79
52-Week Range
5.05–9.13
Volume
185.90K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.50
Valuation
Market Cap
$177.01M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.50
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.92
Financials (FY)
Revenue (FY)
$348.67M+3.86%
Net Income (FY)
−$22.75M
Profit marginThe share of revenue left as profit after all costs and taxes.
−6.94%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
26.54M
1-Year Return
−21.44%
Dividend and dates
Earnings Date
November 5, 2026
Avg Volume
299.23K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, INGN closed at $6.67, −21.44% over 1 year.

Inogen, Inc. (INGN) has a market capitalization of $177.01M.

In fiscal 2025, INGN reported revenue of $348.67M.

INGN Stock Return by Calendar Year

Inogen, Inc. (INGN) 10-year return: what $10,000 became

1 year
$10,000 $7,856
−21.44%
5 years
$10,000 $1,597
−84.03%
10 years
$10,000 $1,140
−88.60%

If you had invested $10,000 in Inogen, Inc. (INGN) 10 years ago, at the close on October 21, 2016, it would have been worth $1,140 at the close on October 21, 2026: −88.60% in total, −19.52% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−0.74%
2025−26.72%
2024+67.03%
2023−72.15%
2022−42.03%
2021−23.90%
2020−34.61%
2019−44.97%
2018+4.27%
2017+77.28%
2016 (partial year)+22.62%

As of October 21, 2026.

INGN Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$348.67M−$22.75M−6.5%
2024$335.71M−$35.89M−10.7%
2023$315.66M−$102.45M−32.5%
2022$377.24M−$83.77M−22.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$348.67M$154.27M−$30.21M−$22.75M−6.5%
2024$335.71M$154.74M−$42.52M−$35.89M−10.7%
2023$315.66M$126.70M−$76.49M−$102.45M−32.5%
2022$377.24M$153.53M−$33.08M−$83.77M−22.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

INGN Valuation vs Medical Devices Median

Median of 145 stocks
MetricINGNMedical Devices medianvs median
P/S ratio0.502.530.2x the median
Profit margin−6.94%−14.78%7.8 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 12 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Inogen, Inc. (INGN) is capitalised at $177.01M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 753.

Over the past 52 weeks the price has ranged from $5.05 to $9.13. INGN last closed at $6.67 on October 21, 2026. That is −$0.02 (−0.30%) against the previous close. The latest close sits 32.21% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $348.67M. That is +3.86% against the prior fiscal year, when revenue was $335.71M. The same year closed with a net loss of $22.75M. Profit margin runs at −6.94%. That is 7.8 percentage points above the Medical Devices median of −14.78%. Trailing earnings per share are −0.92.

Across the 4 fiscal years on file, revenue moves from $377.24M in 2022 to $348.67M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 0.5 times revenue. On price-to-sales that is 0.2 times the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The reported beta is 1.5. Daily returns over the trailing 10 years annualize to a volatility of 57.23%. The trailing one-year total return is −21.44%. Measured over 10 years, that is −19.52% a year compounded.

Growth & Income

The record shows no dividend for INGN.

The strongest complete calendar year on file is 2017 at +77.28%; the weakest is 2023 at −72.15%. Of the 9 complete calendar years on file, 3 finished higher. 2026 is still running; the total return is −0.74% year to date.

Peer Comparison

Inogen, Inc. (INGN) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Inogen, Inc. INGN $177.01M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Inogen, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Inogen, Inc.

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Visit website →